Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.
The first needle-free adrenaline treatment launches in the UK, validating non-invasive delivery with real-world data ...
Weekly intramuscular injections of rotigotine extended-release microspheres are linked to significant symptom improvement in ...
The lower dose was associated with the need for an additional epinephrine dose, epinephrine infusion, or intubation compared ...
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today ...
A man who surrendered his life to heroin and lived as an addict for nearly a quarter of a century is now a mental health ...
11don MSN
Albumin-recruiting lipid nanoparticles could make future mRNA vaccines safer and more effective
A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Tsinghua ...
Often fuelled by a dire shortage of qualified nurses and the weak enforcement of health regulations, auxiliary nurses - ...
While its AI smarts are impressive, I'm not sure I'm ready to switch all my internet browsing over to this new release .
A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Tsinghua ...
Uzedy administered once every 2 months is not recommended for the maintenance treatment of bipolar I disorder. The Food and Drug Administration (FDA) has approved Uzedy ® (risperidone extended-release ...
GSK’s ViiV Healthcare and its bimonthly pre-exposure prophylaxis (PrEP) medicine Apretude had to make room for another long-acting PrEP option this summer, when rival Gilead Sciences rolled out Yez | ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback